Cargando…

1324. Identification of Local Risk Factors for P. aeruginosa in Community-acquired Pneumonia in a Veteran Population

BACKGROUND: The 2019 ATS/IDSA community-acquired pneumonia (CAP) guidelines recommend empiric P. aeruginosa (PSA) coverage if locally validated risk factors are present. They further recommend obtaining local data on CAP pathogens to quantify risk factors and help guide clinical decision-making. To...

Descripción completa

Detalles Bibliográficos
Autores principales:	Gibbons, Emily A, Hopkins, Teri L, Yang, Linda, Frei, Christopher R, Restrepo, Marcos I, Walter, Elizabeth, Cadena-Zuluaga, Jose
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2021
Materias:	Poster Abstracts
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8644971/ http://dx.doi.org/10.1093/ofid/ofab466.1516

Ejemplares similares

234. Dalbavancin versus Outpatient Parenteral Antimicrobial Therapy with Vancomycin for Treatment of Bone and Joint Infections in a Veteran Population
por: Gibbons, Emily A, et al.
Publicado: (2021)

Clinical utility of methicillin-resistant Staphylococcus aureus nasal PCR to streamline antimicrobial use in treatment of diabetic foot infection with or without osteomyelitis
por: Harb, Gaielle, et al.
Publicado: (2023)

2821. A Comparison of Empirical Therapy with Cefazolin Versus Ceftriaxone for the Treatment of Complicated Urinary Tract Infections in a Tertiary Care VA Medical Center
por: Carcamo, Paola, et al.
Publicado: (2023)

1317. Prevalence of Pseudomonas aeruginosa as the Causative Organism for Community Acquired Pneumonia
por: Haviland, Adam D, et al.
Publicado: (2021)

P1324: A RISK-BASED STRATEGY FOR THE USE OF LETERMOVIR IN CMV-POSITIVE RECIPIENTS OF ALLOGENEIC HEMATOPOIETIC CELL TRANSPLANTATION
por: Beauvais, D., et al.
Publicado: (2022)

758. Increased Prevalence of Clostridioides difficile Infection During the COVID-19 Pandemic Among Hospitalized Veterans in South Texas, USA
por: Young, Eric H, et al.
Publicado: (2021)

2133. Clinical Impact of Implementation of Rapid Diagnostic Testing of Blood Cultures on Patient Outcomes
por: Gritte, Anndee, et al.
Publicado: (2019)

1499. Incidence of Community Acquired Pneumonia by Age and Comorbid Conditions in the Veterans Health Administration (VHA)
por: Bej, Taissa A, et al.
Publicado: (2020)

Antimicrobial Treatment of Community-Acquired Pneumonia
por: Restrepo, Marcos I., et al.
Publicado: (2005)

1324. Impact of Implementation of CSF PCR Panel in Patients with Meningitis
por: Hsu, Eric, et al.
Publicado: (2023)

1040. Comparative Characteristics of Patients With Pseudomonas Bacteremia Receiving Intravenous Only vs. Intravenous Followed by Oral Therapy
por: Vu, Trung, et al.
Publicado: (2018)

360. Evaluation of Cycle Threshold Values in Patients with Symptomatic COVID-19 Infection
por: Dixon, Danielle, et al.
Publicado: (2021)

1298. Validation of Local Pseudomonas aeruginosa Risk Factors in Patients with Community-Onset Bacterial Pneumonia
por: Pizzuti, Morgan, et al.
Publicado: (2021)

Eighteen New Aeruginosamide Variants Produced by the Baltic Cyanobacterium Limnoraphis CCNP1324
por: Cegłowska, Marta, et al.
Publicado: (2020)

Prognostic role of TSPAN1, KIAA1324 and ESRP1 in prostate cancer
por: Stinnesbeck, Melissa, et al.
Publicado: (2021)

P1324: EFFICACY AND SAFETY OF DOSE-ADJUSTED ATG COMBINED WITH CD25 ANTIBODY IN THE PREVENTION OF GVHD AFTER HAPLO-HSCT: CLINICAL STUDY DATA FROM A SINGLE CENTER IN CHINA
por: Zhu, Lidan, et al.
Publicado: (2023)

Community-acquired pneumonia treated on the ICU
por: Apostolidou, E, et al.
Publicado: (2006)

Community-acquired, hospital-acquired, and healthcare-associated pneumonia caused by Pseudomonas aeruginosa
por: Fujii, Ayumi, et al.
Publicado: (2014)

1628. Treatment Heterogeneity in Pseudomonas aeruginosa Pneumonia
por: Caffrey, Aisling, et al.
Publicado: (2020)

165. Comparative Effectiveness of Oral Fluoroquinolones vs. β-Lactams for the Treatment of Patients with Enterobacteriaceae Bloodstream Infections
por: Bjork, Lauren, et al.
Publicado: (2019)

N-linked glycosylation is essential for anti-tumor activities of KIAA1324 in gastric cancer
por: Yun, Rebecca, et al.
Publicado: (2023)

1324. Target Attainment of Exebacase, a First-In-Class Antibacterial Lysin, to Determine Optimal Doses for Adult Patients with Staphylococcus aureus (S. aureus) Bloodstream Infections (Bacteremia) Including Endocarditis
por: Ghahramani, Parviz, et al.
Publicado: (2020)

75. Less is More: A Physician-Driven Quality Improvement Stewardship Initiative to Reduce Excessive Duration of Antibiotic Therapy in Veterans Hospitalized with Community-Acquired Pneumonia
por: Monday, Lea M, et al.
Publicado: (2020)

Systemic corticosteroids for community-acquired pneumonia in adults
por: Pugh, RJ, et al.
Publicado: (2012)

Mathematical modeling of community-acquired pneumonia patients
por: Sarkar, J, et al.
Publicado: (2009)

Middle molecules in severe community-acquired pneumonia
por: Dumitras, T, et al.
Publicado: (2015)

Prognostic assessment in community-acquired pneumonia by pneumonia severity scores and biomarkers
por: Dusemund, F, et al.
Publicado: (2010)

Erratum: Xu, Y., et al. Computational Studies on Acetylcholinesterases. Molecules 2017, 22, 1324
Publicado: (2017)

Severe community-acquired pneumonia in the intensive care unit
por: Costa, C, et al.
Publicado: (2005)

Host genetic variants associated with community-acquired pneumonia
por: Salnikova, LE, et al.
Publicado: (2013)

Outcome of severe community-acquired pneumonia: the impact of comorbidities
por: Pereira, JM, et al.
Publicado: (2013)

Racial disparities in quality of care in community-acquired pneumonia
por: Mayr, FB, et al.
Publicado: (2008)

Disparities of Care for African-Americans and Caucasians with Community-Acquired Pneumonia: A Retrospective Cohort Study
por: Frei, Christopher R, et al.
Publicado: (2010)

Comparative-Effectiveness of Oral Beta-Lactams and Fluoroquinolones for Stepdown Therapy in Patients with Enterobacterales Bloodstream Infections: A Retrospective Cohort Study
por: Bjork, Lauren, et al.
Publicado: (2023)

A clinical pathway for community-acquired pneumonia: an observational cohort study
por: Frei, Christopher R, et al.
Publicado: (2011)

Severe community-acquired pneumonia: risk factors for in-hospital mortality
por: Pereira, JM, et al.
Publicado: (2012)

Severity of illness scoring systems in community-acquired Legionella pneumonia
por: Simonsen, Ø, et al.
Publicado: (2010)

Validation of predictive rules for ICU patients with community-acquired pneumonia
por: Rudnov, V, et al.
Publicado: (2008)

1484. Microbial Etiology of Community-acquired Pneumonia in Immunocompromised Patients
por: Deshpande, Abhishek, et al.
Publicado: (2020)

1324. Penicillin-Susceptibility among Staphylococcus aureus Skin-and-Soft-Tissue Infections at a Children’s Hospital
por: McNeil Jonathon, C, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_q8ibp5vtlk181mqsb58oldrfgk